GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease
Microglia, the resident immune cells of the central nervous system (CNS), are responsible for maintaining homeostasis in the brain by clearing debris and are suggested to be inefficient in Alzheimer’s Disease (AD), a progressive neurodegenerative disorder for which there is no disease-modifying drug...
Main Authors: | Sarah M. Connor, Mamunur Rashid, Katie J. Ryan, Kruti Patel, Justin D. Boyd, Jennifer Smith, Wassim Elyaman, David A. Bennett, Elizabeth M. Bradshaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2022.894601/full |
Similar Items
-
Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors
by: Chien-Chang Kao, et al.
Published: (2022-04-01) -
The Oxindole GW-5074 Inhibits JC Polyomavirus Infection and Spread by Antagonizing the MAPK-ERK Signaling Pathway
by: Jacob Kaiserman, et al.
Published: (2023-04-01) -
VEGF controls microglial phagocytic response to amyloid-β
by: Priscille de Gea, et al.
Published: (2023-12-01) -
A New Understanding of TMEM119 as a Marker of Microglia
by: Chunsheng Ruan, et al.
Published: (2022-06-01) -
Functional insight into LOAD-associated microglial response genes
by: Lauren A. Jonas, et al.
Published: (2022-01-01)